REN and chronic kidney disease: Indeed, blockade of the renin-angiotensin system with ACE inhibitors and ARBs, ostensibly as a consequence of their ability to lower intraglomerular pressure, have been repeatedly shown to reduce the rate of GFR decline in both diabetic and non-diabetic settings [30, 31], placing them along with blood pressure control at the forefront of CKD management.